Mawer Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Mawer Investment Management's GILD Position: Q4 2020 in Review
Mawer Investment Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 339,387 shares — an estimated $21.4M sold.
Mawer Investment Management first reported a position in GILD in Q3 2016 and held it in 17 quarters. The position peaked at $72.5M in Q1 2020. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- Mawer Investment Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
- Mawer Investment Management sold 339,387 Gilead Sciences shares in Q4 2020, an estimated $21.4M.
- Mawer Investment Management first reported a position in Gilead Sciences in Q3 2016 and held it in 17 quarters.
- Mawer Investment Management's Gilead Sciences position peaked at $72.5M in Q1 2020.
- 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on Mawer Investment Management's 13F filing for Q4 2020, filed 9 Feb 2021.